Cerner's products are meant to help the healthcare system operate more efficiently. Does exposure to strong long-term growth trends make Cerner's stock a buy?
News & Analysis: Cerner
Investors can expect Cerner to grow its top line by 6% to 9% over the next five years.
The healthcare technology provider met its revenue guidance and beat its adjusted earnings guidance, thanks primarily to growth in its services business.
CERN earnings call for the period ending June 30, 2019.
Both companies are digitizing healthcare, but one is executing better.
CERN earnings call for the period ending March 30, 2019.
The big healthcare-technology provider hit its first-quarter guidance thanks to solid professional services and managed services revenue growth.
The activist investment firm is pushing a program of change for the healthcare tech company.
Find out how one of these stocks gained ground despite tepid financial performance.
Shares jump after management reaches a deal with an activist investor. Here are the must-know details.